Oregon Lawmakers Consider Letting One County Raise Local Cannabis Taxes

Lawmakers in Oregon are considering a bill to allow some municipalities in the province to raise local taxes on adult-use cannabis from the 3% cap to no more than 10%, the Argus Observer reports. If the bill is passed, voters would have the final say in approving the measure during the General Election.

The bill would allow cities in counties with a population of 30,000 or more and border a state where cannabis remains outlawed to raise the tax rate, the report says. State Sen. Lynn Findley (R) said during a Monday work session on the legislation that there are three counties in Oregon which border Idaho, where cannabis is illegal, but only one – Malheur County – has a population that would meet the bill’s requirements; and in the county, only Ontario meets those requirements.

“It only affects one county and one city. It’s about as narrow as we can get and still be legal to legislative counsel,” Findley said during the session. He told the Observer that the leader of the state House, who killed the bill last year, said she would support the measure if it included the county and city limits.

“By narrowing it to Malheur County, it will make it more palatable to my colleagues.” Findley to the Observer

The amended proposal now moves to the Senate floor where it could be taken up this week.

The state’s Finance and Revenue Committee also held a public hearing on a measure that aims to relieve counties and cities that lost state cannabis revenues due to the passage of a separate bill that diverted some of those funds for drug treatment programs. That bill would allow the formula for distribution for cannabis revenue to be adjusted annually for inflation.

End


MedMen Withdraws Allegations that Ascend Influenced New York Politicians

Lawyers for Ascend Wellness Holdings said that its legal rival MedMen has moved to withdraw its allegations that Ascend executives put political pressure on Gov. Kathy Hochul’s (D) administration to approve the transfer of MedMen’s medical cannabis license to Ascend, amNY reports. Ascend, a cannabis operator hoping to set up operations in New York which purchased MedMen’s New York operations for $73 million, filed a lawsuit in state court last month against MedMen, a multi-state cannabis company, that claimed the defendant had not fulfilled that contract.

MedMen had filed a counterclaim accusing Ascend of pressuring Hochul’s administration and claimed Ascend executives had met with state officials and donated money to the governor’s campaign in an effort to get the deal done; Ascend has denied those allegations and last week provided evidence supporting that position, the report says.

Mylan Denerstein, a lawyer representing Ascend, told amNY that counsel for MedMen has agreed to withdraw that allegation.

“Like any house of cards, MedMen’s claims collapsed when exposed to the slightest scrutiny. Ascend will continue to correct the record and looks forward to entering New York’s cannabis market once its rights are vindicated in court.” Denerstein in a statement via amNY

Ascend submitted to the court logs and a hotel receipt that show Ascend’s president Andrew Brown providing legal counsel and staying at a hotel in Albany on the day that MedMen accused him of attending the Manhattan fundraiser for Hochul and submitted a receipt that showed CEO Abner Kurtin to be in Florida the day of an alleged meeting with the governor’s secretary.

MedMen did not comment on the withdrawal of the allegations.

End


54K Acres of Industrial Hemp Planted in 2021, Worth $712M

In 2021, 54,200 acres of hemp were planted for industrial purposes in the U.S, valued at $712 million with 33,500 total acres harvested for industrial purposes, according to the U.S. Department of Agriculture’s (USDA) National Hemp Report. Hemp flower production last year was valued at $623 million with farmers cultivating 16,000 acres, with an average yield of 1,235 pounds per acre and a total of 19.7 million pounds grown for flower, the report says.

The production of hemp grown for fiber purposes was estimated by the USDA at 33.2 million pounds over 12,700 acres, with an average yield of 2,620 pounds per acre. The USDA estimates the fiber sector value at $41.4 million.

Production of hemp grown for seed in 2021 was estimated at 1.86 million pounds, with 3,515 acres being used for hemp seed. The USDA reports estimates an average yield of 530 pounds per acre, with a total value of $41.5 million.

The agency report indicates that Colorado led the U.S. in acres of planted hemp with 10,100 but Montana harvested the most hemp – 4,500 acres on 7,900 acres planted, the second-highest hemp acreage total planted in the U.S. in 2021. Hemp acreage planted in Texas and Oklahoma each reached 2,800 acres, with 1,070 acres of hemp harvested in Texas while in Oklahoma just 275 acres were harvested.

The report notes that last year, 27 states operated under federal guidelines provided by the 2018 Farm Bill instead of implementing state rules, while 22 states operated under state regulations allowed under the 2014 Farm Bill. All of the tribes that cultivated hemp last year operated under the 2018 regime. Only Idaho did not have a regulated hemp program last year but state officials began issuing licenses last month.

End


Ayr Wellness Announces ‘Changing Legacies,’ A Series of Expungement Events

Company Teams Up with Community Partners in MA, NY, NJ, IL and NV to Assist Individuals in Obtaining a Fresh Start

MIAMI, February 22, 2022 – Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), today announced the launch of Changing Legacies, a series of record expungement clinics scheduled to take place on February 27, 2022.

As part of the series, Ayr has partnered with numerous not-for-profit and community organizations with expertise in social justice and legal and criminal justice reform. The Company and its partners specifically designed each clinic to assist individuals in expunging cannabis and other non-violent crimes from their records, allowing an opportunity for a fresh start.

“Despite the legalization of cannabis across 35+ states – two-thirds of the US population – the criminal justice system still grapples with a host of issues related to the War on Drugs, which continues to disproportionately impact Black and Brown Americans,” said Jonathan Sandelman, Founder, Chairman and CEO of Ayr. “We believe it is critical to be part of the solution to these issues, addressing the harms of the past and creating opportunity for the future. The main objective of our ‘Changing Legacies’ program is to create an ecosystem of support, partnership and hope for that better future. We thank our partnering organizations for making an event like this possible.”

Ayr will host these expungement events in conjunction with local community partners in multiple states across the country. These events will serve as models for similar events going forward, expressing Ayr’s ongoing commitment to righting harms of the past and creating opportunities for the future.

Community partners play an essential role in promoting equity and fairness in cannabis in America, and Ayr is actively seeking more partnership opportunities for similar events in the future. If you are interested in collaborating with Ayr, please reach out to socialimpact@ayrwellness.com.

Ayr is currently calling on community organizations across the country that may be interested in hosting similar events in the future, and encourages them to reach out to the Company via socialimpact@ayrwellness.com. More information regarding Ayr’s Changing Legacies events, along with Ayr’s latest social impact activations, can be found on the Ayr Wellness Social Impact Instagram Page, @ayrsocialimpact.

*In Nevada, Ayr will be collecting donations at Nevada retail locations (The Dispensary NV and Mynt) between February 18 and March 4, which will directly support Project Clean Slate.

About Ayr Wellness Inc.
Ayr is an expanding vertically integrated, U.S. multi-state cannabis operator, focused on delivering the highest quality cannabis products and customer experience throughout its footprint. Based on the belief that everything starts with the quality of the plant, the Company is focused on superior cultivation to grow superior branded cannabis products. Ayr strives to enrich consumers’ experience every day through the wellness and wonder of cannabis.
Ayr’s leadership team brings proven expertise in growing successful businesses through disciplined operational and financial management, and is committed to driving positive impact for customers, employees and the communities they touch. For more information, please visit www.ayrwellness.com.

Company/Media Contact:
Robert Vanisko
VP, Corporate Communications
Email: robert.vanisko@ayrwellness.com

Investor Relations Contact:
Sean Mansouri, CFA
Elevate IR
Email: ayr@elevate-ir.com
Email: IR@ayrwellness.com

 

End


New York Gov. Signs Bill Allowing Conditional Cannabis Cultivation Licenses

New York Gov. Kathy Hochul (D) on Tuesday signed the bill creating conditional adult-use cannabis licenses which will allow current hemp cultivators in the state to apply for a license to grow adult-use cannabis during the 2022 growing season.

The bill was approved by the Legislature last week. Under the law, conditionally licensed cannabis farmers must meet certain requirements, including safe, sustainable, and environmentally friendly cultivation practices, participation in a social equity mentorship program, and engagement in a labor peace agreement with a bona fide labor organization. The bill is an effort to prevent shortages of cannabis when adult-use sales begin, likely sometime in 2023.

“I am proud to sign this bill, which positions New York’s farmers to be the first to grow cannabis and jumpstart the safe, equitable and inclusive new industry we are building. New York State will continue to lead the way in delivering on our commitment to bring economic opportunity and growth to every New Yorker in every corner of our great state.” – Hochul in a statement

Cannabis Control Board Chair Tremaine Wright said the timing of the bill is “critical” to the agency’s efforts to roll out the adult-use program and noted that the mentorship provisions “put equity and inclusion at the forefront of the new cannabis industry” in the state.

Office of Cannabis Management Executive Director Chris Alexander said the bill provides regulators “with the tools to make up for lost time.”

“With this bill, we’re putting New York farmers, not big corporations, at the forefront of our industry while protecting public health by delivering safely grown products,” he said in a statement. “We are immediately getting to work implementing the bill so that our farmers can start planting this spring.”

With a conditional adult-use cannabis cultivation license, farmers can grow outdoors or in a greenhouse for up to two years from the issuance of the license. It also allows them to manufacture and distribute cannabis flower products without holding an adult-use processor or distributor license, until June 1, 2023. Cultivators are limited to one acre (43,560 square feet) of flowering canopy outdoors or 25,000 square feet in a greenhouse and can use up to 20 artificial lights. They can also split between outdoor and greenhouse grows with a maximum total canopy of 30,000 square feet as long as the greenhouse flowering canopy remains under 20,000 square feet.

End


Veriheal Acquires MarijuanaDoctors.com for $3M

Health technology company Veriheal has acquired MarijuanaDoctors.com in a $3 million deal, giving the firm the largest network of physicians in the medical cannabis space and expanding its network of strategic dispensary partnerships.

The revamped site will include secure electronic medical record tools, online appointment scheduling, 24/7 support via live chat and phone, and a larger network of doctors, the company said.

Anthony Dutcher, CMO at Veriheal, said that “the need for medical cannabis has exploded” amid the coronavirus pandemic. A survey by the company last year found during the pandemic, 55% of patients who applied for medical cannabis cards said their main reason for using cannabis was “to feel happy.”

“It is through the legitimizing of medical cannabis at the federal level where we will see profound growth in the medical markets financially, but also for widespread healing.” – Dutcher in a statement

Veriheal noted that the company has experienced 6,000% growth over a 4-year period, adding that it has spent five years building strong, HIPAA-compliant data technology solutions to help medical cannabis patients book appointments with licensed doctors who can certify for medical cannabis cards and wellness visits throughout the U.S.

End


Psilocybin Regulations Bill Advancing In Oregon Senate

An Oregon Senate committee has passed a proposal to ensure the state’s emerging psilocybin program grows in a socially equitable manner, Marijuana Moment reports. Sponsored by state Sen. Lawrence Spence (D) and Rep. Wlnsvey Campos (D), the bicameral measure passed the Senate Human Services, Mental Health and Recovery Committee unanimously, with two members excused, earlier this month.

The measure seeks to create a 15-person task force made up of lawmakers, psilocybin regulators, experienced psychedelics treatment practitioners, and representatives of the indigenous community. Only one committee, Ways and Means, remains between the bill and a floor vote in the Senate.

Voters in Oregon passed the ballot measure to legalize psilocybin for therapeutic purposes in 2020. The measure legalized the “manufacture, delivery and administration” of the psychedelic compounds and rules have begun to emerge from the advisory board in charge of creating the system to regulate the drug which shows the state is leaning toward allowing only one species of mushroom, Psilocybe cubensis, for psilocybin manufacturing.

Additionally, early reporting shows synthetic psilocybin would not be permitted in Oregon, according to Oregon Public Broadcasting.

“It is kind of a landmark moment because Oregon is the very first state to have created such a system of regulation,” Mason Marks, a member of Oregon’s psilocybin advisory board and a senior fellow on the Project on Psychedelics Law and Regulation at Harvard Law School said in the report. “These are the very first draft rules that we’re seeing, so it really is a kind of pivotal event.”

End


Wells Fargo Analyst: Trucker Shortage Due to Cannabis Prohibition

A top Wells Fargo analyst suggested that federally mandated drug testing for cannabis is contributing to the worker shortage and rising prices in the trucking industry, according to a Marijuana Moment. Wells Fargo’s Chief Equity Strategist Chris Harvey’s comments came during a conference call last week when Harvey described the drug tests as creating “a very tight market even worse” as more states legalize cannabis for adult use and said that the mandates exclude “a significant portion of that trucker industry.”

The comments were first reported by CNBC’s Carl Quintanilla on Twitter.

“If you’ve listened to one conference call or a thousand conference calls, what have you heard? Logistics, transportation costs, trucker costs all going higher and that’s going to continue to occur. And the reason being is very simple. And some of you know this and some, this may be new it’s really about drug testing. We’ve legalized marijuana in some states but, obviously, not all but some. And what you have as a trucker is you have a federal mandate for drug testing.” Harvey via Twitter

A New York Post report from last year found 72,000 truckers were removed from their jobs due to a failed drug test for cannabis. More recently, Rep. Ed Perlmutter (D) said during a House Rules Committee hearing that the labor shortage at the U.S. Postal Service could be due in part to federal cannabis prohibition, Marijuana Moment reported.

Activists and opponents both agree that it is not safe to operate a large truck while intoxicated; however, THC remains detectable on drug tests for as long as 30 days.

End


Colombian President Approves Cannabis Industry Regulation Measure

Colombian President Ivan Duque on Sunday approved a measure to regulate medical cannabis products in food and beverages, allow for industrial hemp, and allow exports of dried cannabis, Then24 reports. The government’s Resolution 27 of 2022 regulates the decree approved last year in connection with the licenses, quotas, and authorizations for medical access to cannabis use, including cannabis derivatives and hemp products.

“This resolution allows, defines and establishes all the mechanisms and procedures for the industrial use of cannabis in sectors such as food, beverages and also textile uses, defining, of course, that these uses have to do with the non-psychoactive component. … [Colombia] is at the forefront of the regulation of the use of medical cannabis in Latin America and the Caribbean and, of course, its derivations from industrial uses.” – Duque via Then24

Bill Petron, CEO of PharmaCielo – the Canadian parent company PharmaCielo Colombia Holdings S.A.S which cultivates and produces dried flower and medical-grade cannabis extracts in Colombia, described the development as “historic” for the Colombian cannabis industry. He explained that it will “open the large and growing global dried flower market as well as multiple CBD-based opportunities to Colombia producers.”

“The Colombian government has consistently demonstrated its desire to build this industry into a global leader, and in our opinion, the announcement today makes Colombia the most export-friendly and competitive jurisdiction in the world,” Petron said in a statement. “Dried flower accounts for up to 50% market share in most mature cannabis markets globally, and represents a massive opportunity both for the Colombian industry, and PharmaCielo.”

Minister of Health Fernando Ruiz called the legislation “very important” to guarantee “good manufacturing practices” and told Then24 that the door is opened to “produce dietary supplements,” among other products.

End


South Dakota Police Arrest Patients Enrolled in Tribal Medical Cannabis Program

Law enforcement officials in South Dakota are arresting people who have been issued a medical cannabis card by the Flandreau Santee Sioux Tribe, contending that the cards are not valid for non-tribal members, according to a KFGO report. The tribe operates the only medical cannabis dispensary currently operational in the state.

Tribal officials told KFGO that more than 100 people who have been issued a card by the tribe have been arrested since the dispensary opened in July. The state Department of Public Safety and the attorney general’s office have taken the position that the medical cannabis cards aren’t valid for non-tribal members and Flandreau Police Chief Zach Weber told KFGO that his department is following that directive and arresting people with cards if they are not tribe members.

In 2020, 70% of South Dakota voters approved a medical cannabis ballot initiative and state lawmakers approved most of the Department of Health-authored program rules in September but rejected some parts of the plan including limiting the amount of high-potency cannabis patients can possess, requirements that medical practitioners could write recommendations for patients that want to grow more than the three plants allowed under the law, and a defined list of qualifying conditions. The Legislature’s Rules Review Committee signed off on new program rules as recently as October.

Earlier this month, the South Dakota state Senate voted 25 to 10 to strip an affirmative defense provision from the medical cannabis law, which would have provided some protection for the state’s cannabis patients by allowing those charged with possessing cannabis to get out of the charges by demonstrating a medical need for cannabis, even if they don’t have their medical card yet.

The state Health Department issued its first establishment registration certificates under the program last month, but sales have not yet commenced.

End


Comedy Central’s ‘South Park’ Addresses Inequality In Colorado’s Cannabis Industry

It’s been several years since South Park‘s Randy Marsh, the all-American dad character who fuels many of the Comedy Central show’s comically insensitive subplots, entered the weed business with the marketing-forward brand Tegridy Farms. Since then, showrunners Trey Parker and Matt Stone have skewered the cannabis industry at multiple points and during a recent episode — Episode 2 of Season 25, “The Big Fix,” which premiered February 9 — the show took direct aim at racial inequality in Colorado’s cannabis industry.

The episode opens with Randy attending the 2022 Cannabis Cultivators Expo in Denver, which is not a real event but is clearly modeled after the industry’s B2B conferences.

At a panel titled “The Changing Face of Hemp Farming,” a white speaker tells the crowd that due to growing public awareness about the industry’s racial equalities, white-owned businesses are going to face a harsh reality check to their bottom line:

“We growers must face a harsh reality. Since the legalization of marijuana, communities of color — Black and Brown Coloradans, those most affected by the racist War on Drugs — have now been locked out of the wealth creation of the industry. Luckily, the public is starting to understand this unfairness. And many people are now talking about boycotting cannabis growers who are only white-owned. We are seeing a healthy and dramatic spike in consumers who demand that their marijuana be grown by those who understand the fight for social equity. The bottom line is this: a completely white-owned weed business these days just isn’t going to survive.”

In a panic to save his profits, Randy enacts a plan for his family to get close with the Blacks — the only (and blatantly tokenized) Black family in South Park — so he can coerce Steve, the family’s patriarch, into joining Tegridy Farms as a co-owner.

During the episode, Steve quickly realizes that he’s being used so Randy can say the business is partially Black-owned, so he ultimately quits and launches his own cannabis company. The episode closes with the subplot between Randy and Steve left open-ended but it probably won’t be the last time the show visits the issue this year, considering that South Park‘s latest seasons have featured episodic plotlines.

While “The Big Fix” is not entirely accurate when it comes to the social equity issue in Colorado — characters in the show, for example, suggest that consumer boycotts are going to ruin white-owned businesses but in reality, these businesses are still winning the lion’s share of cannabis industry profits — it is at least exciting to see the issue fueling mainstream discussion.

Note: Tegridy Farms is a fictional cannabis company but the showrunners have announced plans for a real line of Tegridy-branded cannabis products in Colorado.

End


Advocates in Denton, Texas Launch Cannabis Decriminalization Campaign

Advocates in Denton, Texas are conducting a petition drive to decriminalize cannabis in the city, the Fort Worth Star-Telegram reports. The effort is being led by Decriminalize Denton and other groups who are gathering signatures in support of ending citations and arrests for misdemeanor possession.

The campaign’s goal is to get a city ordinance ending the enforcement of low-level cannabis offenses on the November ballot.

Tristan Seikel, a co-founder and organizer for Decriminalize Denton, told the Star-Telegram that it is “really important that Denton keeps pace to where our nation is headed, and that is a more inclusive and equitable approach to cannabis use.”

“This is a huge criminal justice issue, because when you think about it, who are going to be disproportionately targeted by existing cannabis laws in Texas? It’s people who don’t have a safe space to consume, people who don’t have housing or good connection to do that in a safe way.” – Seikel to the Star-Telegram

The proposal states that Denton officers “shall not issue citations or make arrests for Class A or Class B misdemeanor possession of marijuana offenses.” Class A misdemeanors are punishable by up to one year in jail or a fine of up to $4,000 or both while Class B misdemeanors could be met with up to 180 days in jail or a fine of up to $2,000 or both. The measure would also prohibit Denton from using city funds or personnel for THC concentration testing of seized cannabis products and prohibit the city from using the odor of cannabis or hemp as probable cause for search or seizure.

The Denton Police Department did not comment to the Star-Telegram on the petition but outlined its policy for handling cannabis cases, which is to generally issue citations in lieu of arrest when a person is accused of possessing two ounces or less and an officer doesn’t believe another crime has occurred, the policy states. When establishing probable cause to make a cannabis-related arrest, under current department policy, officers cannot use the smell of cannabis alone, and only approved cases are sent for testing, according to the document outlined by the Star-Telegram.

The campaign comes following a successful bid in Austin that will culminate in May when residents will vote on a referendum that would end the enforcement of low-level cannabis offenses and no-knock raids by law enforcement in the city.

Similar campaigns are happening in cities across the Lonestar State with the collaboration of Ground Game Texas, including in Killeen and San Marcos.

The campaign needs 1,745 signatures to get the proposal on the ballot but told the Star-Telegram that the group’s goal is 3,000 signatures.

End


Marijuana Packaging Supplier Acquires 420packaging.com

Miami, FL [December 16, 2021] – Boyne Capital Partners (“Boyne”) is pleased to announce that its portfolio company A&A Global Imports, LLC dba www.marijuanapackaging.com or “MJ Pack” (“A&A”) acquired Aphecal Enterprises, Inc. dba www.420packaging.com (“Aphecal” or the “Company”), a leading supplier of packaging materials and ancillary products to the high-growth medical and recreational cannabis industry.

Since 2013, the Company has provided a one-stop-shop for its customers, offering approximately 2,500 products, including packaging products (such as glass jars, pop top bottles, vials, tubes, and retail exit bags) and other ancillary goods. As part of the transaction, A&A also acquired the intellectual property related to the manufacture of Squeezetops®, a popular brand of regulatory compliant, child-resistant containers. In addition to its flagship website, www.420packaging.com, the Company operates the highly trafficked www.smokecones.com and www.humiditypacks.com which focus on various cannabis-related ancillaries.

Boyne Managing Partner and CEO, Derek McDowell, said, “A&A is committed to pursuing strategic acquisitions where it can leverage its robust supply chain and marketing expertise to drive growth. Aphecal is a prime example of an opportunity where A&A can bring more products to more customers at market leading pricing. We look forward to pursuing more great investments with the A&A team.”

David Aryan, A&A founder and CEO said, “We’re very excited to have closed on this acquisition. Aphecal will broaden our reach while allowing us to enhance the product portfolio on Aphecal’s already impressive e-commerce platform. At the same time, the IP we’ve gained will fit perfectly within our portfolio of exclusive products. The Boyne team and the M&A expertise they’ve brought to A&A has proven a great asset.”

A&A is a platform investment in BCM Fund II (“Fund”). Boyne Capital is dedicated to investing in the lower middle market sector, specifically companies with revenues of less than $100 million and with EBITDA of $3 million to $15 million.

About Boyne
Boyne Capital Partners is a Florida-based private equity firm focused on investments in lower middle market companies. Founded in 2006, Boyne has successfully invested in a broad range of industries, including healthcare services, consumer products, manufacturing, and business & financial services. Beyond financial resources, Boyne provides industry and operational expertise to its portfolio companies and partners with management to drive company performance and growth. Boyne specializes in providing the capital necessary to fund corporate growth and facilitate owners and shareholders’ partial or full exit. For additional information, please visit www.boynecapital.com.

Contact Joshua Bilmes at jbilmes@boynecapital.com or 786.539.2245 regarding new opportunities.

End


Sweeping Cannabis Legalization Bill Introduced in Missouri

A cannabis legalization omnibus bill was introduced last week in Missouri, which would legalize cannabis for adults, allow regulated sales, expunge prior cannabis-related crimes, allow individuals on parole and probation to use cannabis, create tax deductions for medical cannabis patient fees and for cannabusinesses that can’t deduct business expenses from federal returns, create protections for the state’s banks to serve the industry, and allow bars, restaurants, and lodging establishments to provide spaces to consume cannabis, Ozark Radio News reports.

Republican State Rep. Ron Hicks, the bill’s sponsor, said in a memo to colleagues that the “Cannabis Freedom Act” was drafted in a way to incorporate elements from “every marijuana bill filed this session” to create a “free but tightly regulated market for legal marijuana,” according to a Marijuana Moment report.

“The Cannabis Freedom Act is the product of input from many different stakeholders including members of law enforcement and those who have endured incarceration for conduct that society now deems acceptable.” – Hicks in a statement via Ozark Radio News

In a joint statement, New Haven Police Chief Chris Hammann and former Carter County prosecutor Rocky Kingree expressed support for the legislation.

“Law enforcement does not need to be tasked with the thankless job of marijuana prohibition anymore,” they said, “and the Cannabis Freedom Act allows for the reparative justice actions that will continue the work of repairing the relationship and trust between the government and its citizens.”

If passed, the reforms would take effect in Missouri on August 28. The measure includes six co-sponsors, including four Republicans and two Democrats. It is not currently assigned to a House calendar.

End


New Zealand Police Revive Cannabis Eradication Program

Police in New Zealand have budgeted more than $600,000 for a national cannabis eradication program a year after the operation was canceled, Stuff reports. Officials had quietly ended the practice in January 2021, saying that the leaders of the nation’s 12 police districts no longer backed the program.

According to the report, six police districts are participating in the revived eradication operation. The other six districts indicated they would continue managing local cannabis eradication as needed and are not participating in the nationally coordinated effort.

According to a briefing of the program outlined by Stuff, the action, dubbed Operation Emerald, began in January and will run until next month.

“Running a nationally coordinated operation provides efficiencies in terms of negotiating a fixed-wing plane and helicopter contracts, deploying staff, provision of training for staff, and administration of the budget.” ‘Operation Emerald’ briefing via Stuff

The initial operating budget for the eradication program was $575,000 and would come out of police’s baseline funding. The budget has since increased to $635,000 due to increased costs, a police spokesperson told Stuff.

Green Party MP Chlöe Swarbrick said the only “successful bust” lawmakers have heard about from the program was of three plants grown by a couple in Coromandel. The homeowner told Stuff that police flew a helicopter over their property and spayed their plants while they were eating dinner. The individual said the money budgeted by police for the eradication program would have been better spent on criminals doing real harm … [instead of] medical growers and very small scale one or two plant growers causing little or no harm.”

Swarbrick said that the program has been around since the 1980s.

“Its failure is so profound that even cheerleaders of prohibition can’t see the irony in their argument that cannabis is now far stronger than it ever used to be precisely because of these actions, which continue to push cannabis production and consumption underground into unregulated spaces,” she told Stuff.

In 2020, New Zealanders rejected a non-binding cannabis referendum 53% to 46%.

End


Alabama Senate Committee Approves Cannabis Decriminalization Bill

The Alabama Senate Judiciary Committee on Wednesday approved a bill to decriminalize cannabis possession in the state, the Associated Press reports. However, the bill sponsor, Democratic state Sen. Bobby Singleton admitted that the bill’s chances of passing the Legislature is “not bright considering it is an election year.”

The committee had approved an identical version of the bill last year, but it never made it to the floor in either chamber for a full vote. It passed the committee on a 5-4 vote.

“What we’re doing is basically trying to just make sure that we are not locking people up on marijuana charges.” – Singleton to the AP

Under the proposal, the first two convictions for possessing two ounces of cannabis or less would still be a misdemeanor but would be met with lower fines than current state law and would not include incarceration. Under current Alabama law, possession of any amount of cannabis for personal use is punishable by up to a year in prison and a maximum fine of $6,000, according to NORML. The reform measure would replace those penalties with a $250 fine for the first offense and a $500 fine for the second offense. The third offense would be adjudicated as a felony punishable by a $750 fine but no jail time.

The proposal also includes expungement provisions for previous low-level cannabis charges. The measure would allow individuals convicted of possession to petition the courts to have their records expunged, so long as the person doesn’t have any other violations except for minor traffic violations misdemeanors or felonies in the preceding five years.

Alabama is one of just 19 states that still impose jail time for simple cannabis possession. A February 12 poll by Civiqs found that 62% of Alabamans support broad cannabis legalization in the state with 24% opposed.

End


CNN CHS Coverage Light on Sources; Cherry Picks Data

In a September 17 article focused on cannabinoid hyperemesis syndrome (CHS) CNN’s coverage uses just one source (quality and gatekeeping bias) in its narrative, falling short of basic journalism standards. Additionally, the article claims that “CHS can be life-threatening” despite no one ever dying from the condition (omission bias). The article also cherry picks data from a 2019 study when describing CHS as “a national problem.”

Presence of bias:

“Between 2005 and 2014 when only medical marijuana was legal in most states, a 2020 study found nearly one in five people hospitalized for cyclical vomiting in the US reported concurrent cannabis use,” the CNN article contends. News organizations should, at the very least, find individuals from both sides to build their narrative, and while it’s no secret that news organizations have deeply cut their science staff (CNN fired its entire science team in 2008), their reporters are still responsible for being able to communicate scientific issues and stories.  

While the study that pushes their CHS narrative does state that one in five CHS hospitalizations have concurrent cannabis use, CNN does not include any context about the study (which was limited by its inability to individually review charts), uses data from an administrative dataset (which the authors note are “susceptible to inaccurately entered or missing codes”), and is a retrospective study which risks residual confounding.

“We would also like to highlight that this perceived increase in cannabis use could at least partially be due to more established guidelines in diagnosing [CHS]. Rome criteria for [CHS] were established in 2006 and knowledge about this condition has increased since then. CHS was also first described in 2004 and awareness regarding the association of cannabis with these disorders has also increased,” the study authors wrote. “Therefore, the recognition bias could be contributing to both the observed trends in the increase in hospitalizations due to CVS, as well as, the increase in the documented cannabis use in CHS patients.”

The tone of the article is decidedly prohibitionist, and we may be able to start calling CNN out soon for structural bias – the organization itself having a bias against cannabis. The coverage includes no opposing voices or even those from other researchers which limits its ability to tell a clear and honest story. Even the story’s last heading “Concerns for the future” smacks of fear-mongering.

How to remedy:

CNN needs to include other voices in its coverage, include proper context when describing previous research, and shift to a more even tone in its cannabis coverage. It is their duty to find a cannabis researcher, rather than rely on reporters who are certainly not experts in the field. With this minor change, CNN’s narrative would be more balanced and science-oriented rather than pushing their narrative which is bereft with tone, omission, and quality bias.

End


New York Times Follows Trend of Fear Mongering With Story Focused on Edibles and Children

Editor’s note: this article is part of our new series, “Cannabias,” where resident journalist and media studies professor TG Branfalt uses an academic lens to pinpoint concrete examples of anti-cannabis in the mainstream news. For a full introduction to the series and the framework TG uses to identify bias, click here.


The New York Times on January 14 published an article titled “More Young Kids Are Getting Sick From Cannabis Edibles” – a headline which you’ll find monthly in some form or fashion kicking around. Overall, the Times does balance the piece with its last four graphs explaining how consumers can prevent their children from accessing cannabis edibles. However like most other authors that cover this issue, they fail to note the very simple premise: of course more kids are getting sick because cannabis is legal which has led to a proliferation of edibles, and now that cannabis is legal parents are naturally going to be more likely to bring their children to ERs in these situations because there is less fear of arrest or other punishment.

Presence of bias:

Yeah, I know I’ve been here before, ranting about personal responsibility but it bears repeating – it’s up to the parents to keep cannabis out of the hands of children. Gun owners make the argument all the time, “Guns don’t kill people, people do.” Well, cannabis edibles that are safely locked up or out of reach don’t give kids exposure sickness; it’s down to the people who are irresponsible with such products. That’s the ideal.

Moreover, about halfway through the piece, the author states that Dr. Sharon Levy, the director of the Adolescent Substance Use and Addiction Program at Boston Children’s Hospital, told her that “Many adults and teenagers alike generally assume that edible marijuana products are harmless.” This is attribution bias, as you would be hard-pressed to find any responsible adult who thinks cannabis is totally benign, and teenagers are probably not the best indicator of what is and isn’t harmless. Levy also makes broad generalizations that are included in the story, such as “a whole lot more psychosis and cannabinoid hyperemesis syndrome” but neither Levy nor the author backs up these claims (context bias).

How to remedy:

Instead of going with another alarmist headline and fear-mongering story, why not focus on what parents can do better? That story could offer real solutions, instead of pushing the tired narrative that brands are creating infused candy that children just can’t wait to gobble up. Would the Times bother to run a story about how hard cider and hard seltzer packaging are reminiscent of popular soda brands or Capri Sun? Probably not, and keep in mind: alcohol poisoning actually kills people.

I will credit the Times with not using “weed” or “pot” in the coverage here, but I would also have liked to see some statistics on kids being accidentally exposed to alcohol or pharmaceutical drugs, or an acknowledgment that high-potency edibles are often used by patients with severe health conditions, either of which would help balance the story.

End


Fox News: No Fairness or Balance in Coverage of San Francisco Cannabis Tax Suspension

Recently, officials in San Francisco, California voted unanimously to suspend the implementation of its voter-approved cannabis tax. Supervisor Rafael Mandelman, who sponsored the bill to suspend the tax, cited the “illegal market” and “out-of-control retail theft” as the reasons for the tax’s suspension.

On December 5, Fox News published a report on the plan with the headline: “San Francisco crime surge prompts city to suspend cannabis tax to help dispensaries versus drug dealers” and while the statement is generally accurate, it contains adjective bias with its use of the term “drug dealers.”

Presence of bias:

By using the term “drug dealers,” Fox is continuing to demonize cannabis as a dangerous “drug,” and purports that those selling cannabis without state- or city-issued permits are dangerous as well.

The Fox News report also completely ignores that this tax had been previously suspended due to the city’s logistical issues getting businesses the permits they need to sell cannabis legally. This creates a context bias by not including the fact that the city had already not implemented the tax and the city would remain unaffected by the second suspension.

Additionally, the Fox News article describes San Francisco as having a “staggering surge in crime during the past year,” however, the city’s own crime statistics indicate increases among some crimes, while reporting decreases in others – including a 5.1% decrease in robberies, a 13.2% decrease in rape, and a 3.1% decrease in burglaries from Jan. 1, 2021 to Dec. 12, 2021. The statistics do show increases in homicides – from 46 the previous year to 53 this year – and assaults (2,075 in 2020 to 2,271 in 2021); but the overall increase in the city’s crime rate (10.2%) seems to be largely driven by larceny theft – from 24,474 to 28,947 (an 18.3% increase).

The crime statistics do, objectively, show a crime increase but, again, the Fox News article fails to address the contextual issues associated with that increase (and “drug dealing” is not one of them).

An Atlantic article from September dives into the “crime wave” increase claims from 2020 and concluded that “America is in the midst of what is specifically a violence wave, not a broad crime wave.”

“Even as violent crime rose, led by significant jumps in murders and aggravated assaults,” David A. Graham writes, “property crime continued a years-long decline.”

Philip Cook, a crime expert at Duke University described last year’s increase in crime as “no crime wave,” rather “a tsunami of lethal violence, and that’s it.”

Yes, in late November, there was a “wave of robberies” at cannabis dispensaries, including in San Francisco, as we at Ganjapreneur reported; however, the argument could be made that cannabis businesses are targeted due to federal law forcing them to operate mostly in cash, rather than attribute it to a national trend.

The Fox News article also employs a false-balance bias in their last graph, pointing to a “mob of thieves” in Oakland – not San Francisco – that targeted dispensaries and traditional pharmacies. High-end stores in San Francisco’s Union Square were, in fact, targeted by looters last month; however, Fox News doesn’t mention those crimes as they don’t fit their narrative that dispensaries and pharmacies are key targets (and are therefore dangerous for communities), making it appear that “drugs” are the culprit, rather than criminals.

Fox News also fails to link the increase in crime rates with unemployment as studies have indicated, when the unemployment rate rises, property crimes rate rise with it by 1.8% to as much as 4%.

How to remedy:

Fox News is always going to put its own spin on stories – and target ‘liberal’ cities in the process – but including some city statistics, evidence from the city it is covering rather than relying on other cities to prove its point, and using fair phrasing (unregulated sales versus “drug dealers”) would provide the fairness and balance Fox News purports to convey in its reporting.

End


CNN’s Cannabis and Sleep Headline Doesn’t Jive with Reality or Article Content

A Dec. 6, 2021 CNN article boasts the headline “Marijuana may make sleep worse, especially for regular users, study finds;” yet midway through provides a more accurate line that should have informed the header – that there is “no clear evidence either way” that cannabis actually makes sleep worse. CNN kind of has a penchant for skewing their cannabis coverage and that trend continues in this piece focused on a sleep-and-cannabis-related study.

Presence of bias:

From the context bias in the alarmist headline to the tone bias in the second subheader (“Still, people continue to believe that weed is helping their sleep,”) CNN is making claims it later walks back and uses a negative tone in its description of how cannabis, anecdotally, helps some people.

The statement midway through the article from lead study author Calvin Diep, a resident in the department of anesthesiology and pain medicine at the University of Toronto, noted that there is a disconnect between what cannabis consumers report and evidence behind it, which is empirically true, but most non-cannabis industry reporters seem to forget that cannabis research has been outlawed since the enaction of prohibition. The statement from Diep should not be buried midway through the article (an example of structural bias) but rather should appear in the first couple of graphs

The article also cites several people who were not involved in any way with the study, which can be a great way to balance study-related stories; however, CNN runs a quote from Bhanu Prakash Kolla, a sleep medicine specialist in the Center for Sleep Medicine at the Mayo Clinic, that claims cannabis consumers who stop regular use experience sleep disruptions due to withdrawal symptoms. It should be noted that Kolla is not an expert on cannabis, and the assertion about “withdrawal symptoms” should be taken with a grain of salt – and certainly not published without additional supporting evidence or context. The choice to only use medical experts who do not specialize in cannabis amounts to gatekeeping bias.

The article also makes the suggestion that cannabis is more potent now than ever before – a claim which is not backed by science, as we only know the actual cannabinoid concentrations of cannabis products now that it has been legalized. Our parents may say, “this is a lot stronger than what I smoked back in the seventies,” but the truth is there is no way to tell, honestly, whether cannabis cultivated during prohibition was weaker than what is available now. Making this claim is also an example of adjective bias.

And as usual, deep within the piece is where the chosen headline is fully revealed as clickbait. The author closes with a quote from Dr. Karim Ladha, staff anesthesiologist and clinician-scientist in the department of anesthesiology and pain medicine at the University of Toronto, who provides perhaps the most honest quote in the whole article, which would have made for a much better headline: “The studies just give us the possibilities that (marijuana) could hurt your sleep, but it may help and so we just don’t know until you try it.”

An article free of bias will never call cannabis “weed” or any other street name; second, if cannabis helps people sleep, then it helps people sleep. It’s not something they “believe” – it’s their experience as consumers. A simple baseline for quality reporting is to avoid implying something with words such as “still.” The headline is misleading; just look a few graphs into the piece and you’ll find your baseline for an objective headline. To their credit, CNN’s use of the word “cannabis” (13) outpaced “marijuana” (9) and “weed” (8) but the organization still has a lot of work to do when covering cannabis, as their clickbait-style headlines on the topic tend to tilt toward the anti-cannabis camp.

How to remedy:

CNN should avoid make sweeping generalizations, whether it be about the potency of cannabis or via phrases such as “people continue to believe.” Maybe find some people who actually use cannabis for sleep and get their take? Scientists and researchers can add balance, but they are going to try and stick to what they know (their experiences) and not including the voices of any consumers does this piece a great disservice. And enough with using “weed” as a synonym for cannabis in your reporting, especially when it’s painfully obvious that you don’t have any real familiarity with the plant.

End


CNN Cannabis Heart Attack Report Strikes Alarmist Tone

CNN’s article, “Young adult cannabis consumers nearly twice as likely to suffer from a heart attack, research shows,” suffers from several biases, including tone, oversimplification, and omission.

Presence of bias:

Tone bias is apparent in the first graph and is meant to scare readers but the study – like the CNN article – “confuses absolute risk for relative risk and makes a huge deal out of 1% risk turning into a 2% risk,” Dr. Mitch Earleywine wrote on Facebook. This assessment may be an indictment of the study itself, but also illuminates the simplicity bias apparent in the CNN report on the study.

“’Some people assume that consuming cannabis is safe and can’t harm your body, but that is incorrect,’ said lead study author Dr. Karim Ladha, clinician-scientist and staff anesthesiologist at St. Michael’s Hospital and the University of Toronto in Canada. ‘There’s increasing evidence that this could potentially be harmful to you, both in the short term and the long term,’ he said.”

“Some people” is an over-generalization and the story fails to dive deeper on Ladha’s claims.

First of all, “some people” assume a lot of things that aren’t true. Most people know that inhaling smoke is not what our bodies were designed to do. Are there “some people” who smoke cannabis and think they are not being harmed in any way by that method of consumption? Sure, but there are also “some people” who believe that smoking tobacco and drinking alcohol aren’t harmful either. When compared with the well-known harms of tobacco and alcohol and the hundreds of thousands of deaths per year attributed to them, does the doctor’s comment actually warrant the level of alarm projected by this article, or does this comment actually refer to the widely-held (and evidence-backed) assumption that cannabis seems to be less harmful than other substances? Careful readers will also note Ladha’s use of the word “potentially.” He’s not being nearly as firm on his position as the article would lead the reader to believe.

Additionally, the article never tells us the primary ingestion method of the 73 cannabis consumers (of the 5,610) enrolled in the study who had a heart attack but the lede doesn’t take this into consideration and strikes an alarmist tone. Also, were these people smokers? Did they use any pharmaceuticals, what was their diet, any drugs, how many children?

“The study did not research how cannabis affects heart health, Ladha said, but he noted that previous research showed the drug can affect a user’s heart rate,” the article states.

Okay, where are the studies, CNN? Not including them is omission bias plain and simple. Your header says, “It can create an irregular heart rate.” Prove it.

Next, CNN shifts to the potency issue. Why? Aside from being alarmist? Did the study know the potency of the cannabis used by the 73 afflicted consumers? This is an example of simplicity bias because the narrative benefits the prohibitionist narrative that we need to keep cannabis outlawed because it is, allegedly, stronger than it was 50 years ago (which happened during prohibition, CNN).

How to remedy:

CNN included zero voices from anyone within the sphere of cannabis legalization. There are thousands of cannabis experts in the U.S. and Canada (including Dr. Mitch) that they could have reached out for comment to, but they instead relied on the study author (whose job is to defend his research) and the chair of the American Heart Association – which, it should be noted, does support removing cannabis from Schedule I under the Controlled substances act. However, their chosen expert does not speak to the study itself, but rather in oversimplified terms. The article would have certainly been fairer had the reporter included scientific voices from within the cannabis industry, referenced the health risks of other legal substances, or mentioned any of the numerous studies that have suggested potential therapeutic value of cannabis in treating a wide variety of conditions. The lede could also have been more honest, instead of implying all methods of cannabis consumption were carefully documented, which they weren’t.

End


Cannabis Legalization Bill Filed In Kentucky

Democratic lawmakers in Kentucky on Thursday filed legislation to legalize cannabis for adults in the state and tax sales, the Louisville Courier-Journal reports. The bill, however, is likely a longshot in the Republican-controlled General Assembly which over the past decade has failed to pass bi-partisan medical cannabis reforms.

The bill is sponsored in the House by state Rep. Rachel Roberts and in the Senate by state Sens. Morgan McGarvey and David Yates. It also includes provisions to automatically expunge cannabis-related misdemeanor charges within one year.

“While cannabis will not be a panacea for all that ails the state, Kentucky stands to gain up to $100 million a year if our sales near those of our neighbors in Michigan and Illinois – but not if we keep letting neighboring states beat us to the punch.” – Roberts, during a press conference, via the Courier Journal

The measure includes a tax rate of up to 11%, including the state’s 6% sales tax and an optional 5% local tax.

The proposal would create a seven-member Cannabis Control Board that would be appointed by the governor and confirmed by the Senate. It would also create a 19-member Social Impact Council which would use a portion of state proceeds for scholarships and grants to those that have been subject to “historical overuse of criminal justice responses,” the report says. In 2018, the state reported 7,600 cannabis-related arrests, Roberts said, while a 2020 American Civil Liberties Union report found Black Kentuckians were 9.4 times more likely than white Kentuckians to be arrested for cannabis possession; the national rate of cannabis arrest disparities among Black people and white people is 3.64 times.

McGarvey told the Courier-Journal that he believes there will be bipartisan support for the reforms.

“I think you’d be surprised how many lawmakers from both sides of the aisle, all across the state, are coming up in the hallways and in the chamber saying ‘it’s time we do something to legalize marijuana in Kentucky,'” he said in the report.

The House did pass a medical cannabis bill in 2020 but it was not taken up by the Senate. Another medical cannabis bill introduced by Republican Rep. Jason Nemes this session has not been assigned to a committee.

End


Italy High Court Tosses Voter-Backed Cannabis Reform Referendum

Italy’s Constitutional Court struck down a proposed voter initiative that would have eased restrictions on growing cannabis and other cannabis-related offenses, according to a Reuters report. Giuliano Amato, president of the high court and a former prime minister, said the proposal included policies that were “enough to make us violate multiple international obligations.”

Although unclear, Amato may be referring to the inclusion of psilocybin in the ballot effort.

Riccardo Magi, a lawmaker and leading supporter of the initiative, said the decision was a “terrible blow to democracy.”

“It’s almost impossible to hold a referendum in Italy,” he said in the report.

The court also threw out a ‘right to life’ voter petition along with the cannabis proposal. Combined, the two potential ballot measures gathered 1.8 million signatures but still failed to pass the court’s inspection. However, five lesser-known judicial system-related measures did pass court scrutiny and will be in front of voters later this year, Reuters notes.

Last year organizers of the ballot measure said they collected 500,000 signatures in just one week, prior to submitting it to the court. They believed the effort “would put an end to unnecessary trials for small amounts of the drug and ensure that patients who use it to relieve their excruciating pain will never have to face a court again.”

In December, fellow European Union member Malta became the first country in the union to legalize adult-use cannabis. Germany’s new coalition government, meanwhile, last November announced it would move to legalize cannabis.

End


Washington State Fails to Pass Cannabis Industry Social Equity Bill

A Washington bill to increase social equity in the state’s cannabis industry failed to clear the House on Tuesday, The Chronicle reports. The bill had lost the support from several Democratic lawmakers over issues related to how many licenses would be issued, concerns with the bill’s grant and loan requirements, zoning law issues, and the elimination of the buffer requirements for cannabis retailers.

The substitute version of the bill that was advanced to the House removed the phrase “racial minorities” from the social equity definition, cut the social equity grant and low-interest loan fund from $22.5 million to $3 million – but kept the $1.1 million technical assistance program to help applicants navigate the cannabis licensing process – and removed one of the key features of the bill that would have created new licenses specifically for social equity applicants through 2029.

The bill rejected by lawmakers also removed a mobility clause that supporters said was key in equitably distributing the 39 retail licenses the state’s Liquor and Cannabis Board currently has available. However, of those licenses, 20 are in jurisdictions that do not currently allow cannabis operations, and 17 are in parts of Washington where the markets are likely unprofitable, the report says.

“I think it just takes a little bit more work with the Liquor and Cannabis Board to try to figure out how the licensing could be distributed in a way to make sure that, especially as the forfeit of licenses come into play, that they go to the social equity program,” House Majority Leader Rep. Pat Sullivan told The Chronicle.

Two other bills concerning racial equity and the cannabis industry passed both the House and Senate prior to Tuesday’s end of session, but neither were able to be heard by the other chamber.

End